More articles from Clinical Decision-Making
- The difficulties of differentiating vasculitis from its mimics
The signs and symptoms of vasculitis are not specific, and the tests for it can be misleading.
- The diagnostic utility of c-ANCA in Wegener’s granulomatosis
A positive c-ANCA may suggest Wegener’s granulomatosis, but in most cases it should not be used instead of biopsy to make the diagnosis.
- Interpreting serologic tests for hepatitis C virus infection: balancing cost and clarity
ELISA screening tests for HCV have unacceptably high false-positive rates. Newer tests are more accurate, but costly.
- Acute myelogenous leukemia in first complete remission
Outcomes can be predicted by, and therapy tailored to, specific prognostic factors, such as age and karyotype.
- Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective?
A recommendation that bone scanning not be routinely used for follow-up after successful treatment for early-stage breast cancer.
- New series: Clinical decision-making at the crossroads
A new series, illuminating how physicians, faced with multiple good choices and issues of cost-effectiveness, make everyday diagnostic and treatment decisions.